WEKO3
アイテム
{"_buckets": {"deposit": "2ef7504e-8c59-4e16-8799-8ea2d553adfc"}, "_deposit": {"created_by": 11, "id": "3336", "owners": [11], "pid": {"revision_id": 0, "type": "depid", "value": "3336"}, "status": "published"}, "_oai": {"id": "oai:shiga-med.repo.nii.ac.jp:00003336", "sets": ["193"]}, "author_link": ["3728", "6420", "4554"], "item_4_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2017-03", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "179", "bibliographicPageStart": "173", "bibliographicVolumeNumber": "8", "bibliographic_titles": [{"bibliographic_title": "Case Reports in Ophthalmology"}]}]}, "item_4_creator_3": {"attribute_name": "著者別名", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "東山, 智明"}], "nameIdentifiers": [{"nameIdentifier": "6420", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "00640145", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=00640145"}]}, {"creatorNames": [{"creatorName": "村木, 早苗"}], "nameIdentifiers": [{"nameIdentifier": "4554", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "90335175", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=90335175"}]}, {"creatorNames": [{"creatorName": "大路, 正人"}], "nameIdentifiers": [{"nameIdentifier": "3728", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "90252650 ", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=90252650 "}]}]}, "item_4_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Laser therapy has been the gold standard treatment for retinopathy of prematurity (ROP), while intravitreal bevacizumab (IVB) is reported to be of significant benefit for zone I ROP. A problem with laser therapy is that it is difficult to administer in ROP patients with severely dilated tunica vasculosa lentis and poor mydriasis. However, although IVB treatment has been performed in such severe ROP cases, only 1 report has discussed its usefulness. Case1:A male infant was born with a birth weight of 382 g at 23 weeks\u0027 gestation. As visualization was poor and laser therapy could not be performed due to dilated tunica vasculosa lentis and poor mydriasis, IVB (0.625 mg/0.025 mL) was administered to both eyes. Following treatment, the ROP gradually improved, with regression of the dilated tunica vasculosa lentis and improvement of the mydriasis in both eyes. Case2:A male infant was born with a birth weight of 698 g at 25 weeks\u0027 gestation. As laser therapy could not be performed due to severely dilated tunica vasculosa lentis and poor mydriasis, IVB (0.625 mg/0.025 mL) was administered to both eyes. Following treatment, the ROP gradually improved, with regression of the dilated tunica vasculosa lentis and improvement of the mydriasis in both eyes. Conclusion:IVB is potentially more useful than laser therapy for the treatment of severe ROP with dilated tunica vasculosa lentis and poor mydriasis.", "subitem_description_type": "Abstract"}]}, "item_4_description_42": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"subitem_description": "Journal Article", "subitem_description_type": "Other"}]}, "item_4_publisher_32": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Karger AG"}]}, "item_4_relation_10": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "28611651", "subitem_relation_type_select": "PMID"}}]}, "item_4_relation_11": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1159/000461575", "subitem_relation_type_select": "DOI"}}]}, "item_4_rights_12": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission."}]}, "item_4_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1663-2699", "subitem_source_identifier_type": "ISSN"}]}, "item_4_version_type_15": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Higashiyama, Tomoaki"}], "nameIdentifiers": [{"nameIdentifier": "6420", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "00640145", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=00640145"}]}, {"creatorNames": [{"creatorName": "村木, 早苗"}], "nameIdentifiers": [{"nameIdentifier": "4554", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "90335175", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=90335175"}]}, {"creatorNames": [{"creatorName": "OHJI, Masahito"}], "nameIdentifiers": [{"nameIdentifier": "3728", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "90252650 ", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=90252650 "}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2018-11-19"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "000461575.pdf", "filesize": [{"value": "1.1 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensefree": "©2017 The Author(s). Published by S. Karger AG, Basel\nwww.karger.com/cop", "licensetype": "license_free", "mimetype": "application/pdf", "size": 1100000.0, "url": {"label": "000461575.pdf ", "url": "https://shiga-med.repo.nii.ac.jp/record/3336/files/000461575.pdf"}, "version_id": "8edd55a0-c368-4fd5-804d-86b791c0cb45"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Retinopathy of prematurity", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Intravitreal bevacizumab", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Laser therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Tunica vasculosa lentis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Mydriasis", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis.", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis."}]}, "item_type_id": "4", "owner": "11", "path": ["193"], "permalink_uri": "http://hdl.handle.net/10422/00012469", "pubdate": {"attribute_name": "公開日", "attribute_value": "2018-11-19"}, "publish_date": "2018-11-19", "publish_status": "0", "recid": "3336", "relation": {}, "relation_version_is_last": true, "title": ["Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis."], "weko_shared_id": -1}
Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis.
http://hdl.handle.net/10422/00012469
http://hdl.handle.net/10422/00012469dedfecf5-1fb5-4b5d-9565-ade9c068539a
名前 / ファイル | ライセンス | アクション |
---|---|---|
000461575.pdf (1.1 MB)
|
©2017 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cop |
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2018-11-19 | |||||
タイトル | ||||||
タイトル | Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis. | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Retinopathy of prematurity | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Intravitreal bevacizumab | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Laser therapy | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Tunica vasculosa lentis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Mydriasis | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Higashiyama, Tomoaki
× Higashiyama, Tomoaki× 村木, 早苗× OHJI, Masahito |
|||||
著者別名 |
東山, 智明
× 東山, 智明× 村木, 早苗× 大路, 正人 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Laser therapy has been the gold standard treatment for retinopathy of prematurity (ROP), while intravitreal bevacizumab (IVB) is reported to be of significant benefit for zone I ROP. A problem with laser therapy is that it is difficult to administer in ROP patients with severely dilated tunica vasculosa lentis and poor mydriasis. However, although IVB treatment has been performed in such severe ROP cases, only 1 report has discussed its usefulness. Case1:A male infant was born with a birth weight of 382 g at 23 weeks' gestation. As visualization was poor and laser therapy could not be performed due to dilated tunica vasculosa lentis and poor mydriasis, IVB (0.625 mg/0.025 mL) was administered to both eyes. Following treatment, the ROP gradually improved, with regression of the dilated tunica vasculosa lentis and improvement of the mydriasis in both eyes. Case2:A male infant was born with a birth weight of 698 g at 25 weeks' gestation. As laser therapy could not be performed due to severely dilated tunica vasculosa lentis and poor mydriasis, IVB (0.625 mg/0.025 mL) was administered to both eyes. Following treatment, the ROP gradually improved, with regression of the dilated tunica vasculosa lentis and improvement of the mydriasis in both eyes. Conclusion:IVB is potentially more useful than laser therapy for the treatment of severe ROP with dilated tunica vasculosa lentis and poor mydriasis. | |||||
書誌情報 |
Case Reports in Ophthalmology 巻 8, 号 1, p. 173-179, 発行日 2017-03 |
|||||
出版者 | ||||||
出版者 | Karger AG | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1663-2699 | |||||
PMID | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | PMID | |||||
関連識別子 | 28611651 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1159/000461575 | |||||
権利 | ||||||
権利情報 | This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
資源タイプ | ||||||
内容記述タイプ | Other | |||||
内容記述 | Journal Article |